Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-09-27
2005-09-27
Powers, Fiona T. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S311000, C514S340000, C514S365000, C514S374000, C546S144000, C546S167000, C546S270400, C546S271400, C548S204000, C548S236000
Reexamination Certificate
active
06949566
ABSTRACT:
A compound of the formula (I):wherein R1is hydroxy and the like; R2is optionally substituted lower alkyl and the like; R3is hydrogen atom and the like; R4is optionally substituted arylene and the like;R5is a group represented by the formula:and the like; R6is optionally substituted aryl and the like,its optically active substance, its prodrug, their pharmaceutically acceptable salt, or solvate thereof and metalloproteinase inhibitors containing them.
REFERENCES:
patent: 6423729 (2002-07-01), Kurihara et al.
patent: 757037 (1997-02-01), None
patent: 0950656 (1999-10-01), None
patent: 1029541 (2000-08-01), None
patent: WO 99/04780 (1999-02-01), None
Ho et al., “Gene Expression, Purification and Characterization of Recombinant Human Neutrophil Collagenase,” Gene, vol. 146, pp. 297-301 (1994).
Okada et al., “Matrix Metalloproteinase 9 (92-kDa Gelatinase/Type IV Collagenase) from HT 1080 Human Fibrosarcoma Cells,” The Journal of Biological Chemistry, vol. 267, No. 30, pp. 21712-21719 (1992).
Okada et al., “Matrix Metalloproteinase 2 from Human Rheumatoid Synovial Fibroblasts,” Eur. J. Biochem., vol. 194, pp. 721-730 (1990).
Ward et al., “The Purification of Tissue Inhibitor of Metalloproteinases-2 from Its 72 kDa Progelatinase Complex,” Biochem J., vol. 278, pp. 179-187 (1991).
Knight et al., “A Novel Coumarin-labelled Peptide for Sensitive Continuous Assays of the Matrix Metalloproteinases,” vol. 296, No. 3, pp. 263-266 (1992).
Tamura Yoshinori
Watanabe Fumihiko
Foley & Lardner LLP
Powers Fiona T.
Shionogi & Co. Ltd.
LandOfFree
Thiazole and oxazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazole and oxazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazole and oxazole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3390323